CASI Pharmaceuticals CASI
$ 5.32
1.92%
Quarterly report 2022-Q3
added 11-14-2022
Country |
USA |
IPO year |
- |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ CAPITAL |
CEO |
Dr. Wei-Wu He |
Employees in the company |
125 |
Shares |
136 M |
Market Cap[1] |
$ 724 M |
EBITDA (LTM) |
$ -27.1 M |
P/E (LTM) |
-1.1 |
P/S (LTM) |
0.71 |
EPS (LTM) |
-1.73 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.